Journal of Biomed Research

Continuous, non-invasive optical brain pulse monitoring (OBPM; Cyban Pty. Ltd., Melbourne, Australia) represents a significant advancement in the field of neurological monitoring. OBP monitoring uses red and infrared light sources to capture cardiac and respiratory waves from brain pulse waveforms, which reflect changes in both brain oxygen levels and brain movement.

Secukinumab, a human monoclonal antibody targeting interleukin-17A (IL-17A), is widely used for treating immunoinflammatory disorders. While effective, drug-induced uveitis (DIU) is a rare but serious adverse effect associated with biologic medications like TNF-α inhibitors and more recently, IL-17 inhibitors such as secukinumab. We present a case of posterior uveitis in a 42-year-old male with AS who developed ocular symptoms two years after starting secukinumab.

Diabetic foot ulcers account for 70-80% of all ulcer cases, with this proportion rising to 21–27% in developing countries. The associated mortality rate ranges from 3.75% to 58.8%.

In recent years, immune checkpoint inhibitors (ICIs) have transformed the scope of cancer treatment. Atezolizumab, is a humanized monoclonal antibody that specifically targets programmed death-ligand 1 (PD-L1) to block its interaction with PD-1 and B7-1 receptors, thereby reinstating T cell response.

Dobutamine is a synthetic catecholamine with activity on both alpha-1 and beta-2 adrenoceptors. It is used intravenously as an inotropic agent for short term treatment of heart failure. Dobutamine side effects involve usually cardiovascular system. Cutaneous side effects such as inflammation in the administration site following accidental extravasation could occur. Skin necrosis from intravenous soft tissue infiltration is a rare but serious complication of intravenous therapy. Herein we report a rare case of a local skin necrosis in dobutamine infusion site.